BACKGROUND: Levels of CXCL13, a potent B-cell chemoattractant, are elevated in the cerebrospinal fluid (CSF) during multiple sclerosis (MS) and are associated with markers of MS activity. Levels decrease upon effective treatments. OBJECTIVE: Here we validate the potential role of CSF CXCL13 as a bio...
No comments yet
Be the first to share your thoughts!